Cargando…
Risk of Suicide After Cancer Diagnosis in England
IMPORTANCE: A diagnosis of cancer carries a substantial risk of psychological distress. There has not yet been a national population-based study in England of the risk of suicide after cancer diagnosis. OBJECTIVES: To quantify suicide risk in patients with cancers in England and identify risk factor...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583458/ https://www.ncbi.nlm.nih.gov/pubmed/30476945 http://dx.doi.org/10.1001/jamapsychiatry.2018.3181 |
_version_ | 1783428439430135808 |
---|---|
author | Henson, Katherine E. Brock, Rachael Charnock, James Wickramasinghe, Bethany Will, Olivia Pitman, Alexandra |
author_facet | Henson, Katherine E. Brock, Rachael Charnock, James Wickramasinghe, Bethany Will, Olivia Pitman, Alexandra |
author_sort | Henson, Katherine E. |
collection | PubMed |
description | IMPORTANCE: A diagnosis of cancer carries a substantial risk of psychological distress. There has not yet been a national population-based study in England of the risk of suicide after cancer diagnosis. OBJECTIVES: To quantify suicide risk in patients with cancers in England and identify risk factors that may assist in needs-based psychological assessment. DESIGN, SETTING, AND PARTICIPANTS: Population-based study using data from the National Cancer Registration and Analysis Service in England linked to death certification data of 4 722 099 individuals (22 million person-years at risk). Patients (aged 18-99 years) with cancer diagnosed from January 1, 1995, to December 31, 2015, with follow-up until August 31, 2017, were included. EXPOSURES: Diagnosis of malignant tumors, excluding nonmelanoma skin cancer. MAIN OUTCOMES AND MEASURES: All deaths in patients that received a verdict of suicide or an open verdict at the inquest. Standardized mortality ratios (SMRs) and absolute excess risks (AERs) were calculated. RESULTS: Of the 4 722 099 patients with cancer, 50.3% were men and 49.7% were women. A total of 3 509 392 patients in the cohort (74.3%) were aged 60 years or older when the diagnosis was made. A total of 2491 patients (1719 men and 772 women) with cancer died by suicide, representing 0.08% of all deaths during the follow-up period. The overall SMR for suicide was 1.20 (95% CI, 1.16-1.25) and the AER per 10 000 person-years was 0.19 (95% CI, 0.15-0.23). The risk was highest among patients with mesothelioma, with a 4.51-fold risk corresponding to 4.20 extra deaths per 10 000 person-years. This risk was followed by pancreatic (3.89-fold), esophageal (2.65-fold), lung (2.57-fold), and stomach (2.20-fold) cancer. Suicide risk was highest in the first 6 months following cancer diagnosis (SMR, 2.74; 95% CI, 2.52-2.98). CONCLUSIONS AND RELEVANCE: Despite low absolute numbers, the elevated risk of suicide in patients with certain cancers is a concern, representing potentially preventable deaths. The increased risk in the first 6 months after diagnosis may indicate an unmet need for psychological support. The findings of this study suggest a need for improved psychological support for all patients with cancer, and attention to modifiable risk factors, such as pain, particularly in specific cancer groups. |
format | Online Article Text |
id | pubmed-6583458 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-65834582019-07-05 Risk of Suicide After Cancer Diagnosis in England Henson, Katherine E. Brock, Rachael Charnock, James Wickramasinghe, Bethany Will, Olivia Pitman, Alexandra JAMA Psychiatry Original Investigation IMPORTANCE: A diagnosis of cancer carries a substantial risk of psychological distress. There has not yet been a national population-based study in England of the risk of suicide after cancer diagnosis. OBJECTIVES: To quantify suicide risk in patients with cancers in England and identify risk factors that may assist in needs-based psychological assessment. DESIGN, SETTING, AND PARTICIPANTS: Population-based study using data from the National Cancer Registration and Analysis Service in England linked to death certification data of 4 722 099 individuals (22 million person-years at risk). Patients (aged 18-99 years) with cancer diagnosed from January 1, 1995, to December 31, 2015, with follow-up until August 31, 2017, were included. EXPOSURES: Diagnosis of malignant tumors, excluding nonmelanoma skin cancer. MAIN OUTCOMES AND MEASURES: All deaths in patients that received a verdict of suicide or an open verdict at the inquest. Standardized mortality ratios (SMRs) and absolute excess risks (AERs) were calculated. RESULTS: Of the 4 722 099 patients with cancer, 50.3% were men and 49.7% were women. A total of 3 509 392 patients in the cohort (74.3%) were aged 60 years or older when the diagnosis was made. A total of 2491 patients (1719 men and 772 women) with cancer died by suicide, representing 0.08% of all deaths during the follow-up period. The overall SMR for suicide was 1.20 (95% CI, 1.16-1.25) and the AER per 10 000 person-years was 0.19 (95% CI, 0.15-0.23). The risk was highest among patients with mesothelioma, with a 4.51-fold risk corresponding to 4.20 extra deaths per 10 000 person-years. This risk was followed by pancreatic (3.89-fold), esophageal (2.65-fold), lung (2.57-fold), and stomach (2.20-fold) cancer. Suicide risk was highest in the first 6 months following cancer diagnosis (SMR, 2.74; 95% CI, 2.52-2.98). CONCLUSIONS AND RELEVANCE: Despite low absolute numbers, the elevated risk of suicide in patients with certain cancers is a concern, representing potentially preventable deaths. The increased risk in the first 6 months after diagnosis may indicate an unmet need for psychological support. The findings of this study suggest a need for improved psychological support for all patients with cancer, and attention to modifiable risk factors, such as pain, particularly in specific cancer groups. American Medical Association 2018-11-21 2019-01 /pmc/articles/PMC6583458/ /pubmed/30476945 http://dx.doi.org/10.1001/jamapsychiatry.2018.3181 Text en Copyright 2018 Henson KE et al. JAMA Psychiatry. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License. |
spellingShingle | Original Investigation Henson, Katherine E. Brock, Rachael Charnock, James Wickramasinghe, Bethany Will, Olivia Pitman, Alexandra Risk of Suicide After Cancer Diagnosis in England |
title | Risk of Suicide After Cancer Diagnosis in England |
title_full | Risk of Suicide After Cancer Diagnosis in England |
title_fullStr | Risk of Suicide After Cancer Diagnosis in England |
title_full_unstemmed | Risk of Suicide After Cancer Diagnosis in England |
title_short | Risk of Suicide After Cancer Diagnosis in England |
title_sort | risk of suicide after cancer diagnosis in england |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583458/ https://www.ncbi.nlm.nih.gov/pubmed/30476945 http://dx.doi.org/10.1001/jamapsychiatry.2018.3181 |
work_keys_str_mv | AT hensonkatherinee riskofsuicideaftercancerdiagnosisinengland AT brockrachael riskofsuicideaftercancerdiagnosisinengland AT charnockjames riskofsuicideaftercancerdiagnosisinengland AT wickramasinghebethany riskofsuicideaftercancerdiagnosisinengland AT willolivia riskofsuicideaftercancerdiagnosisinengland AT pitmanalexandra riskofsuicideaftercancerdiagnosisinengland |